Clinical Trials for Mesothelioma Patients: Pemetrexed, Cisplatin, and Vitamin B12 Study
Read about a current clinical trial study being conducted to study the effects of Pemetrexed, Cisplatin, and Vitamin B12 for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.
Intervention:
Drugs: cisplatin; pemetrexed disodium; vitamin B12 Procedures: chemoprotection; chemotherapy; diagnostic procedure; enzyme inhibitor therapy; gene expression analysis; laboratory biomarker analysis; pharmacological study
Study Phase, Type and Design:
Phase II Interventional; Treatment, Non-Randomized Study Design:
Official Title: Phase 2 Pharmacological Study of Pemetrexed Administered With Cisplatin and a Vitamin Supplement in Patients With Nonresectable Pleural Mesothelioma
Courtesy of ClinicalTrials.gov.
Other helpful links:
Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Study description of Cisplatin and Pemetrexed on mesothelioma cancer